Grace Therapeutics, INC. (GRCE) — 10-Q/A Filings
All 10-Q/A filings from Grace Therapeutics, INC.. Browse 2 Amended Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q/A Filings (2)
-
Grace Therapeutics Amends 10-Q for Share Count Correction
— Nov 17, 2025 Risk: low
Grace Therapeutics, Inc. (GRCE) filed a Form 10-Q/A on November 17, 2025, solely to amend the number of outstanding common shares on its cover page for the quar -
Grace Therapeutics Files 10-Q/A for Q3 2024
— Feb 19, 2025 Risk: low
Grace Therapeutics, Inc. filed an amendment (10-Q/A) on February 19, 2025, for the quarterly period ended December 31, 2024. The company, formerly known as Acas
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX